Table 2 The threshold dose prices at the 10th percentile of simulated epidemiological and economic values (over 500 simulations), using both 3.5% and 1.5% discount rates and an increased cost-effectiveness threshold of £30,000, compared to both halted vaccination and girls-only vaccination, with a £10 administration charge per dose
Vaccination strategy | £, versus halted vac. (3.5%) | £, versus girls’ vac. (3.5%) | £, versus halted vac. (1.5%) | £, versus girls’ vac. (1.5%) |
|---|---|---|---|---|
Girls, bivalent | 68.07 | - | 1024.71 | - |
Girls, quadrivalent | 140.85 | - | 1121.74 | - |
Girls, nonavalent | 147.90 | - | 1232.70 | - |
Girls and boys, bivalent | 32.13 | –6.38 | 577.45 | 45.06 |
Girls and boys, quadrivalent | 74.95 | -4.84 | 654.07 | 67.12 |
Girls and boys, nonavalent | 81.12 | -6.04 | 676.54 | 49.89 |